F-18 FDG PET-CT for predicting survival in patients with recurrent glioma: A prospective study

Neuroradiology

Volumn 53, Issue 12, 2011, Pages 1017-1024

  Santra, Amburanjan ^a   Kumar, Rakesh ^b   Sharma, Punit ^b   Bal, Chandrashekhar ^b   Julka, Pramod Kumar ^b   Malhotra, Arun ^b  

^a MEDICAL COLLEGE AND HOSPITAL   (India)

^b ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

FDG PET CT; Glioma; Recurrence; Survival

Indexed keywords

FLUORODEOXYGLUCOSE F 18; TEMOZOLOMIDE;

ADULT; ARTICLE; CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; COMPUTER ASSISTED EMISSION TOMOGRAPHY; CONTROLLED STUDY; DIAGNOSTIC IMAGING; FEMALE; FOLLOW UP; GLIOMA; GRAY MATTER; HISTOPATHOLOGY; HUMAN; IMAGE ANALYSIS; IMAGE DISPLAY; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; OUTCOME ASSESSMENT; PREDICTIVE VALUE; PRIORITY JOURNAL; PROSPECTIVE STUDY; TUMOR RECURRENCE; WHITE MATTER;

ADOLESCENT; ADULT; AGED; BRAIN NEOPLASMS; CHILD; FEMALE; FLUORODEOXYGLUCOSE F18; GLIOMA; HUMANS; INDIA; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; OBSERVER VARIATION; POSITRON-EMISSION TOMOGRAPHY; PREVALENCE; RADIOPHARMACEUTICALS; RISK ASSESSMENT; RISK FACTORS; SURVIVAL ANALYSIS; SURVIVAL RATE; TOMOGRAPHY, X-RAY COMPUTED; YOUNG ADULT;

EID: 83555173439     PISSN: 00283940     EISSN: 14321920     Source Type: Journal    
DOI: 10.1007/s00234-011-0898-3     Document Type: Article

References (37)

1. Levin VA, Leibel SA, Gutin PH (1997) Management of central nervous system neoplasms. In: DeVita VT Jr, Hellman S, Rosenberg SA (eds) Cancer: Principles & Practice of Oncology. Lippincott-Raven Publishers, Philadelphia, pp 2022-2082
2. Kleihurs P, Cavenee WK (eds) (2000) World Health Organization Classification of Tumors: pathology and genetics of tumors of the nervous system. Oxford University Press, New York
3. P Kleihues H Ohgaki 1999 Primary and secondary glioblastomas: from concept to clinical diagnosis Neurooncology 1 44 51 1:STN:280: DC%2BD3MrgtFCktg%3D%3D
4. V Jung BFM Romeike W Henn W Feiden JRM Moringlane KD Zang, et al. 1999 Evidence of focal genetic microheterogeneity in glioblastoma multiforme by area-specific CGH on microdissected tumor cells J Neuropathol Exp Neurol 58 993 999 10499441 10.1097/00005072-199909000-00009 1:CAS:528:DyaK1MXmsFOls7Y%3D (Pubitemid 29441927)
5. Central Brain Tumor Registry of the United States: 2005-2006. Available at http://www.cbtrus.org
6. Bampoe JO, Bauman G, Cairncross JG (1999) Adult low-grade gliomas: natural history, prognostic factors, and timing of treatment. In: Rock JP, Rosenblum ML, Shaw EG, Cairncross JG (eds) The practical management of low-grade primary brain tumors. Lippincott Williams & Wilkins, Philadelphia, pp 135-148
7. J Piepmeier S Christopher D Spencer T Byrne J Kim JP Knisel, et al. 1996 Variations in the natural history and survival of patients with supratentorial low-grade astrocytomas Neurosurgery 38 872 879 8727811 10.1097/00006123- 199605000-00002 1:STN:280:DyaK283ovVOnsg%3D%3D (Pubitemid 26125547)
8. BM McCormack DC Miller GN Budzilovich GJ Voorhees J Ransohoff 1992 Treatment and survival of low-grade astrocytoma in adults-1977-1988 Neurosurgery 31 636 642 1407448 10.1227/00006123-199210000-00004 1:STN:280: DyaK3s%2FisFGitw%3D%3D
9. JN Scott NB Rewcastle PM Brasher D Fulton JA MacKinnon M Hamilton, et al. 1999 Which glioblastoma multiforme patient will become a long-term survivor? A population-based study Ann Neurol 46 183 188 10443883 10.1002/1531-8249(199908) 46:2<183::AID-ANA7>3.0.CO;2-7 1:STN:280:DyaK1MzntFCrsQ%3D%3D (Pubitemid 29382874)
10. G Bauman K Lote D Larson L Stalpers C Leighton B Fisher, et al. 1999 Pretreatment factors predict overall survival for patients with low-grade glioma: a recursive partitioning analysis Int J Radiat Oncol Biol Phys 45 923 929 10571199 10.1016/S0360-3016(99)00284-9 1:STN:280:DC%2BD3c%2FjsF2ktQ%3D%3D (Pubitemid 29525456)
11. PE Ricci 1999 Imaging of adult brain tumors Neuroimag Clin N Am 9 651 669 1:STN:280:DyaK1MvkvVSnsg%3D%3D
12. S Goldman D Wikler P Damhaut M Monclus M Levivier B Pirotte, et al. 1997 Positron emission tomography and brain tumours Acta Neurol Belg 97 183 186 9345590 1:STN:280:DyaK1c%2FgsFCmug%3D%3D (Pubitemid 127514841)
13. S Mirzaei P Knoll H Kohn 2001 Diagnosis of recurrent astrocytoma with fludeoxyglucose F18 PET scanning N Engl J Med 344 2030 2031 11430342 10.1056/NEJM200106283442615 1:STN:280:DC%2BD3MzntlGqsg%3D%3D (Pubitemid 32568163)
14. S Goldman M Levivier B Pirotte JM Brucher D Wikler P Damhaut, et al. 1996 Regional glucose metabolism and histopathology of gliomas. A study based on positron emission tomography guided stereotactic biopsy Cancer 78 1098 1106 8780549 10.1002/(SICI)1097-0142(19960901)78:5<1098::AID-CNCR21>3.0.CO;2-X 1:STN:280:DyaK28znsVamug%3D%3D (Pubitemid 26284876)
15. DD Langleben GM Segall 2000 PET in differentiation of recurrent brain tumor from radiation injury J Nucl Med 41 1861 1867 11079496 1:STN:280:DC%2BD3M%2FktFOltQ%3D%3D
16. ST Chao JH Suh S Raja SY Lee G Barnett 2001 The sensitivity and specificity of FDG PET in distinguishing recurrent brain tumor from radionecrosis in patients treated with stereotactic radiosurgery Int J Cancer 96 191 197 11410888 10.1002/ijc.1016 1:STN:280:DC%2BD3Mzks1GgsQ%3D%3D (Pubitemid 32520674)
17. CG Di E Oldfield DC Wright D De Michele DA Katz NJ Patronas, et al. 1988 Cerebral necrosis after radiotherapy and/or intraarterial chemotherapy for brain tumors: PET and neuropathologic studies AJR Am J Roentgenol 150 189 197 (Pubitemid 18027033)
18. CS Brock H Young SM O'Reilly J Matthews S Osman H Evans, et al. 2000 Early evaluation of tumour metabolic response using [18F]fluorodeoxyglucose and positron emission tomography: a pilot study following the phase II chemotherapy schedule for temozolomide in recurrent high-grade gliomas Br J Cancer 82 608 615 10682673 10.1054/bjoc.1999.0971 1:CAS:528:DC%2BD3cXht1eisLc%3D (Pubitemid 30085198)
19. U Roelcke K von Ammon O Hausmann DL Kaech W Vanloffeld H Landolt, et al. 1999 Operated low grade astrocytomas: a long term PET study on the effect of radiotherapy J Neurol Neurosurg Psychiatr 66 644 647 10209179 10.1136/jnnp.66.5.644 1:STN:280:DyaK1M3islansA%3D%3D (Pubitemid 29186974)
20. K Herholz T Holzer B Bauer R Schröder J Voges RI Ernestus, et al. 1998 11C-methionine PET for differential diagnosis of low-grade gliomas Neurology 50 1316 1322 9595980 1:STN:280:DyaK1c3lsFCiuw%3D%3D (Pubitemid 28240345)
21. B Pirotte S Goldman N Massager P David D Wikler A Vandesteene, et al. 2004 Comparison of 18F-FDG and 11C methionine for PET-guided stereotactic brain biopsy of gliomas J Nucl Med 45 1293 1298 15299051 1:CAS:528: DC%2BD2cXnsFSmur0%3D (Pubitemid 47618525)
22. O De Witte M Levivier P Violon I Salmon P Damhaut D Wikler Jr, et al. 1996 Prognostic value positron emission tomography with [18F]fluoro-2-deoxy-D- glucose in the low-grade glioma Neurosurgery 39 470 477 8875476 (Pubitemid 26292019)
23. JB Alavi A Alavi J Chawluk M Kushner J Powe W Hickey, et al. 1988 Positron emission tomography in patients with glioma. A predictor of prognosis Cancer 62 1074 1078 3261622 10.1002/1097-0142(19880915)62:6<1074::AID- CNCR2820620609>3.0.CO;2-H 1:STN:280:DyaL1czhtVOmsQ%3D%3D
24. VA Levin MD Prados 1992 Treatment of recurrent gliomas and, metastatic brain tumors with a polydrug protocol designed to combat nitrosourea resistance J Clin Oncol 10 766 771 1314890 1:STN:280:DyaK383jsFKksg%3D%3D
25. RE Warnick MD Prados EE Mack KL Chandler F Doz JE Rabbitt, et al. 1994 A phase II study of intravenous carboplatin for the treatment of recurrent gliomas J Neurooncol 19 69 74 7815106 10.1007/BF01051050 1:STN:280:DyaK2M7hsVKnsw%3D%3D (Pubitemid 24258542)
26. G Di Chiro RL DeLaPaz RA Brooks L Sokoloff PL Kornblith BH Smith, et al. 1982 Glucose utilization of cerebral gliomas measured by [18F]fluorodeoxyglucose and positron emission tomography Neurology 32 1323 1329 6983044 (Pubitemid 13218489)
27. M Ishikawa H Kikuchi S Miyatake Y Oda Y Yonekura S Nishizawa 1993 Glucose consumption in recurrent gliomas Neurosurgery 33 28 33 8355844 10.1227/00006123-199307000-00004 1:STN:280:DyaK3szmtFajtQ%3D%3D (Pubitemid 23204808)
28. TJ Janus EE Kim R Tilbury JM Bruner WK Yung 1993 Use of [18F]fluorodeoxyglucose positron emission tomography in patients with primary malignant brain tumors Ann Neurol 33 540 548 8498831 10.1002/ana.410330520 1:STN:280:DyaK3s3ntVCmtg%3D%3D (Pubitemid 23143040)
29. D Kahn KA Follett DL Bushnell MA Nathan JG Piper M Madsen, et al. 1994 Diagnosis of recurrent brain tumor: value of 201T1 SPECT vs 18F- fluorodeoxyglucose PET AJR Am J Roentgenol 163 1459 1465 7992747 1:STN:280:DyaK2M%2FosV2juw%3D%3D
30. NJ Patronas G Di Chiro C Kufta D Bairamian PL Kornblith R Simon, et al. 1985 Prediction of survival in glioma patients by means of positron emission tomography J Neurosurg 62 816 822 2987440 10.3171/jns.1985.62.6.0816 1:STN:280:DyaL2M3htVSqug%3D%3D (Pubitemid 15009404)
31. LM DeAngelis 2001 Brain tumors N Engl J Med 344 114 123 11150363 10.1056/NEJM200101113440207 1:STN:280:DC%2BD3M7ksVWjtQ%3D%3D (Pubitemid 32052502)
32. G Berg E Blomquist E Cavallin-Stahl 2003 A systematic overview of radiation therapy effects in brain tumours Acta Oncol 42 582 588 14596516 10.1080/02841860310014679 (Pubitemid 37193846)
33. FG Barker SM Chang PH Gutin MK Malec MW McDermott MD Prados, et al. 1998 Survival and functional status after resection of recurrent glioblastoma multiforme Neurosurgery 42 709 720 9574634 10.1097/00006123-199804000-00013 (Pubitemid 28208354)
34. D Kondziolka JC Flickinger DJ Bissonette M Bozik LD Lunsford 1997 Survival benefit of stereotactic radiosurgery for patients with malignant glial neoplasms Neurosurgery 41 776 783 9316038 10.1097/00006123-199710000-00004 1:STN:280:DyaK2svmtFOlsQ%3D%3D (Pubitemid 27422104)
35. RA Wolfe RL Strawderman 1996 Logical and statistical fallacies in the use of Cox regression models Am J Kidney Dis 27 124 129 8546126 10.1016/S0272-6386(96)90039-6 1:STN:280:DyaK287jt1ekug%3D%3D (Pubitemid 26017460)
36. MJ Glesby DR Hoover 1996 Survivor treatment selection bias in observational studies: examples from the AIDS literature Ann Intern Med 124 999 1005 8624068 1:STN:280:DyaK283ht1egtA%3D%3D
37. FG Barker II 1996 Analysis of the relationship between long-term operative success and a transient or delayed operative side effect Neurosurgery 39 412 416 8832685 10.1097/00006123-199608000-00043 (Pubitemid 26251567)